Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Tony Gutschner. (2023) RNA therapeutics. RNA Biology 0:0, pages 1-2.
Read now
Read now
Articles from other publishers (14)
Brian J. Thomas, Caitlyn Guldenpfennig, Yue Guan, Calvin Winkler, Margaret Beecher, Michaela Beedy, Ashley F. Berendzen, Lixin Ma, Mark A. Daniels, Donald H. Burke & David Porciani. (2023) Targeting lung cancer with clinically relevant EGFR mutations using anti-EGFR RNA aptamer. Molecular Therapy - Nucleic Acids 34, pages 102046.
Crossref
Crossref
Haichao Zhu, Hong Luo, Ruilong Chang, Yifan Yang, Dingkang Liu, Yue Ji, Hai Qin, Haibo Rong & Jun Yin. (2023) Protein-based delivery systems for RNA delivery. Journal of Controlled Release 363, pages 253-274.
Crossref
Crossref
Rishav Sharma, Rishabha Malviya & Sonali Sundram. 2023. Integration of Biomaterials for Gene Therapy. Integration of Biomaterials for Gene Therapy
417
434
.
Lange Yakubu Saleh, Mikko Ora & Tuomas Lönnberg. (2023) Organomercury oligonucleotide conjugates as artificial ribonucleases. Journal of Inorganic Biochemistry 247, pages 112331.
Crossref
Crossref
Sachiko Horie, Yasuhiro Suzuki, Tsuyoshi Yamamoto, Satoshi Obika, Kohta Mohri, Chizuru Kiyota, Qin Ren, Shota Warashina, Yasuhiro Wada, Yasuyoshi Watanabe, Hidefumi Mukai & Yasufumi Sato. (2023) Novel strategy of liver cancer treatment with modified antisense oligonucleotides targeting human vasohibin‐2. Cancer Science 114:9, pages 3740-3749.
Crossref
Crossref
Robyn McCartan, Olga Khorkova, Claude-Henry Volmar & Claes Wahlestedt. (2023) Nucleic acid-based therapeutics for the treatment of central nervous system disorders. Frontiers in Genetics 14.
Crossref
Crossref
Sabrine Najeh, Kasra Zandi, Nawwaf Kharma & Jonathan Perreault. (2023) Computational design and experimental verification of pseudoknotted ribozymes. RNA 29:6, pages 764-776.
Crossref
Crossref
Tiana Loan Young, Kevin Chang Wang, Andrew James Varley & Bowen Li. (2023) Clinical delivery of circular RNA: Lessons learned from RNA drug development. Advanced Drug Delivery Reviews 197, pages 114826.
Crossref
Crossref
De‐feng Li, Qi‐song Liu, Mei‐feng Yang, Hao‐ming Xu, Min‐zheng Zhu, Yuan Zhang, Jing Xu, Cheng‐mei Tian, Jun Yao, Li‐sheng Wang & Yu‐jie Liang. (2023)
Nanomaterials for
mRNA
‐based therapeutics: Challenges and opportunities
. Bioengineering & Translational Medicine 8:3.
Crossref
Crossref
D. E. Patrushev, E. A. Burakova, S. N. Bizyaev, A. A. Fokina & D. A. Stetsenko. (2023) New Zwitter-Ionic Oligonucleotides: Preparation and Complementary Binding. Molecular Biology 57:2, pages 320-328.
Crossref
Crossref
Yousof Tarverdizadeh, Mohammad Khalili, Saber Esmaeili, Gholamreza Ahmadian, Mehdi Golchin & Abbas Hajizade. (2022) Targeted gene inactivation in Salmonella Typhi by CRISPR/Cas9-assisted homologous recombination. World Journal of Microbiology and Biotechnology 39:2.
Crossref
Crossref
Carme Fàbrega, Anna Aviñó, Natalia Navarro, Andreia F. Jorge, Santiago Grijalvo & Ramon Eritja. (2023) Lipid and Peptide-Oligonucleotide Conjugates for Therapeutic Purposes: From Simple Hybrids to Complex Multifunctional Assemblies. Pharmaceutics 15:2, pages 320.
Crossref
Crossref
Simon Daniel, Zoltán Kis, Cleo Kontoravdi & Nilay Shah. (2022) Quality by Design for enabling RNA platform production processes. Trends in Biotechnology 40:10, pages 1213-1228.
Crossref
Crossref
Ainhoa Martinez-Pizarro & Lourdes R. Desviat. (2022) RNA solutions to treat inborn errors of metabolism. Molecular Genetics and Metabolism 136:4, pages 289-295.
Crossref
Crossref